A simple predictor for donor‐specific anti‐ HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation
HLA · 2024
DOI: 10.1111/tan.15625 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Jia-Ming Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, HLA Antigens, Isoantibodies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Donor‐specific HLA antibody (DSA) has been recognised as an independent risk factor for graft failure in patients undergoing haploidentical haematopoietic stem cell transplantation (HID HSCT). Therapeutic plasma exchange (TPE), as a first‐line strategy for DSA desensitisation, can promptly reduce serum DSA levels. This study aimed to investigate DSA characteristics and identify a biomarker predicting the efficacy of DSA desensitisation in patients proceeding to HID HSCT. We retrospectively enrolled 32 patients with DSA from April 2021 to January 2024, and analysed the mean fluorescence intensity (MFI) value of DSA at the different time points of desensitisation treatment. Compared with baseline DSA level before TPE, the median MFI of HLA class I DSA was reduced from 8178.6 to 795.3 ( p < 0.001), and HLA class II DSA decreased from 6210.9 to 808.8 ( p < 0.001) after TPE. The DSA level in 1:16 diluted pre‐TPE serum correlated well with DSA value in post‐TPE serum (class I, r = 0.85, p < 0.0001; class II, r = 0.94, p < 0.0001), predicting TPE efficacy in 84.4% of patients. Based on the degree of DSA reduction after TPE, patients were divided into complete responders (decreased by >70%), partial responders (decreased by 30 to 70%) and non‐responders (decreased by
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Transfusion Department, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Institute of Haematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,…
ORCID-Profile: Hang Lei, Xiao-Hong Cai
Förderung
- Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Li, J. M., Zhang, Z. L., Zhao, J. L., Wang, Y. Q., Gong, S. S., Lei, H., Wang, X. F., Hu, X. X., & Cai, X. H. (2024). A simple predictor for donor‐specific anti‐ HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation. HLA. https://doi.org/10.1111/tan.15625
Vancouver
Li JM, Zhang ZL, Zhao JL, Wang YQ, Gong SS, Lei H, et al. A simple predictor for donor‐specific anti‐ HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation. HLA. 2024. doi:10.1111/tan.15625
BibTeX
@article{Li2024,
author = {Li, Jia-Ming and Zhang, Zi-Lu and Zhao, Jia-Lu and Wang, Yu-Qing and Gong, Song-Song and Lei, Hang and Wang, Xue-Feng and Hu, Xiao-Xia and Cai, Xiao-Hong},
title = {A simple predictor for donor‐specific anti‐ HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15625}
}
EUVIMED